Skip to main content
. Author manuscript; available in PMC: 2008 Nov 25.
Published in final edited form as: Leuk Res. 2008 Jan 7;32(9):1458–1461. doi: 10.1016/j.leukres.2007.11.030

Figure 3. Clinical Outcomes by CD38 Status.

Figure 3

Figure 3

Figure 3A: TTT curve for patients with Rai stage 0 CLL at diagnosis (NCI 1996 criteria) by CD38 < 30% (n=84) vs CD38 ≥ 30% (n=25)

Figure 3B: OS curve for patients with Rai stage 0 CLL at diagnosis (NCI 1996 criteria) by CD38 < 30% (n=84) vs CD38 ≥ 30% (n=25)